Logotype for PMV Pharmaceuticals Inc

PMV Pharmaceuticals (PMVP) Proxy filing summary

Event summary combining transcript, slides, and related documents.

Logotype for PMV Pharmaceuticals Inc

Proxy filing summary

22 Apr, 2026

Voting matters and shareholder proposals

  • Election of two Class III directors: David H. Mack, Ph.D. and Laurie Stelzer, with board recommendation to vote for both.

  • Advisory vote on executive compensation, with board recommendation to approve.

  • Ratification of Ernst & Young LLP as independent public accounting firm, with board recommendation to approve.

  • Other business may be addressed as appropriate during the meeting or any adjournment.

Board of directors and corporate governance

  • Board recommends the election of two nominees to serve as Class III directors.

Executive compensation and say-on-pay

  • Shareholders are asked to approve, on a non-binding advisory basis, the compensation of named executive officers.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more